Who owns SENTI BIOSCIENCES ORD?
- Ticker: SNTI
- CUSIP Number: 81726a100
Tip: Access positions for across all investors
Analyze quarterly positions in Senti Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Senti Biosciences Ord stock
Who bought or sold SENTI BIOSCIENCES ORD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
NEA Management Company | 4.4M | $1.7M | 0% | Mar 2024 |
|
8vc Gp I | 2.5M | $957k | 0% | Mar 2024 |
|
ARK Investment Management | 1.6M | $615k | -17% | Mar 2024 |
|
Vanguard Group | 707k | $267k | 0% | Mar 2024 |
|
Intel Corporation | 596k | $225k | 0% | Mar 2024 |
|
Triatomic Management | 311k | $117k | 0% | Mar 2024 |
|
Geode Capital Management | 246k | $93k | 3% | Mar 2024 |
|
Omega Fund Management | 196k | $129k | 0% | Dec 2023 |
|
Bridgeway Capital Management | 145k | $55k | 0% | Mar 2024 |
|
Two Sigma Investments | 94k | $35k | 227% | Mar 2024 |
|
Citadel Advisors | 79k | $30k | 81% | Mar 2024 |
|
BlackRock | 40k | $15k | 0% | Mar 2024 |
|
Northern Trust | 37k | $14k | 0% | Mar 2024 |
|
Allen Operations | 21k | $8.1k | 0% | Mar 2024 |
|
Harbour Investments | 15k | $9.9k | 50% | Dec 2023 |
|
Millennium Management | 13k | $5.0k | -7% | Mar 2024 |
|
Tower Research Capital | 8.5k | $3.2k | 100% | Mar 2024 |
|
Morgan Stanley | 1.6k | $603.040000 | 159900% | Mar 2024 |
|
Citigroup | 1.3k | $505.046000 | 100% | Mar 2024 |
|
Wolverine Asset Management | 800.00 | $300.960000 | 0% | Mar 2024 |
|
UBS Group | 732.00 | $275.964000 | 100% | Mar 2024 |
|
Bank of America Corporation | 241.00 | $91.411300 | -95% | Mar 2024 |
|
Wells Fargo & Company | 202.00 | $75.992400 | 2% | Mar 2024 |
|
Brian McDonald | 48.00 | $18.000000 | 0% | Mar 2024 |
|
Who sold out of Senti Biosciences Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Artal Group | Dec 2023 | 56k | $37k |
Bank of New York Mellon | Dec 2023 | 12k | $8.2k |